These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33392662)

  • 1. Percutaneous thermoablation of small renal masses (T1a) in surgical candidate patients: oncologic outcomes.
    Zangiacomo RN; Martins GLP; Viana PCC; Horvat N; Arap MA; Nahas WC; Srougi M; Cerri GG; Menezes MR
    Eur Radiol; 2021 Jul; 31(7):5370-5378. PubMed ID: 33392662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
    Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
    Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
    Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
    Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
    Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
    Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Clinical T1a Renal Mass Ablation in the Octogenarian and Nonagenarian: Oncologic Outcomes and Morbidity.
    Miller AJ; Kurup AN; Schmit GD; Weisbrod AJ; Boorjian SA; Thompson RH; Lohse CM; Kor DJ; Callstrom MR; Atwell TD
    J Endourol; 2015 Jun; 29(6):671-6. PubMed ID: 25386995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
    Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
    Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy.
    Rossi J; Cazzato RL; de Marini P; Auloge P; Autrusseau PA; Dalili D; Tricard T; Poussot B; Garnon J; Lang H; Gangi A
    Cardiovasc Intervent Radiol; 2022 May; 45(5):656-664. PubMed ID: 35274173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
    Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
    Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term follow-up of renal cell carcinomas T1a treated by percutaneous radiofrequency].
    Amadane N; André M; Daniel L; Coulange C; Baboudjian M; Michel F; Gondran-Tellier B; Vanacore D; Lechevallier E; Boissier R
    Prog Urol; 2021 Sep; 31(10):576-583. PubMed ID: 33593696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of CT-guided percutaneous cryoablation of T1a and T1b renal cell carcinoma.
    Spiliopoulos S; Marzoug A; Ra H; Arcot Ragupathy SK
    Diagn Interv Radiol; 2021 Jul; 27(4):524-528. PubMed ID: 34313238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation is an effective treatment option for small renal masses, comparable to partial nephrectomy.
    Pedraza-Sánchez JP; Chaves-Marcos R; Mazuecos-Quirós J; Bisonó-Castillo ÁL; Osmán-García I; Gutiérrez-Marín CM; Medina López RA; Juárez Soto Á
    Eur Radiol; 2023 Nov; 33(11):7371-7379. PubMed ID: 37280356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
    Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
    Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
    Kim HJ; Park BK; Park JJ; Kim CK
    Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
    Zhou W; Herwald SE; Uppot RN; Arellano RS
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
    Yu J; Wang H; Cheng ZG; Liu FY; Li QY; He GZ; Luo YC; Yu XL; Han ZY; Liang P
    Eur Radiol; 2022 Jan; 32(1):89-100. PubMed ID: 34195888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.